Coveo Reports Second Quarter Fiscal 2027 Financial Results

Coveo reported Q2 FY2027 SaaS subscription revenue of $39.1 million, up 9% year over year, and total revenue of $40.4 million, up 8%; Adjusted EBITDA rose to $2.0 million from $0.6 million, while net loss narrowed to $3.1 million from $4.4 million. New business bookings reached a company record, with two seven-figure-per-year deals, and generative AI solutions accounted for more than 50% of quarterly bookings. Coveo announced its acquisition of Anglera and forecast FY2027 revenue of $160–$162 million and Adjusted EBITDA of $2–$7 million; it also repurchased 2,968,659 shares during the quarter.

Analysis

The key tension is leading indicators versus monetization: record bookings and GenAI’s share of new business support pipeline quality, but 102% net expansion (105% excluding legacy Qubit attrition) signals limited organic growth from the installed base. The booking claim matters only if it converts into recurring revenue and lifts retention; two large annual contracts are not yet evidence of broad-based demand. The FY subscription range requires roughly a steady-to-modestly higher quarterly run rate in the second half, while the $2–7m adjusted EBITDA range leaves little visibility on operating leverage. H1 operating cash use also makes the >$10m full-year cash-flow target dependent on a substantial second-half working-capital reversal. Cash provides a buffer, but buybacks and the undisclosed Anglera purchase terms compete with that flexibility.

Near term, the conference call is the catalyst: listen for Anglera consideration, integration costs, bookings-to-revenue timing, and gross retention. Over 1–3 months, conversion of the large deals and evidence that agentic features drive paid expansions matter more than usage claims. Over 6–18 months, enrichment could improve commerce search outcomes, but also creates execution risk and puts Coveo against broader enterprise software and search vendors adding AI features. The contrarian read is that the upbeat bookings narrative may be masking weak expansion and that high-margin revenue growth has not yet translated into consistently positive cash generation. Without valuation and post-release price action, the earnings data alone does not establish an attractive entry.

Key Decisions for Investors

• Avoid chasing an opening move in CVO before the 5 p.m. ET call; seek disclosure on Anglera purchase terms, second-half cash-flow assumptions, and whether bookings are expected to convert within the current guidance horizon.
• Watch, rather than initiate, a small long CVO position after the call. The thesis strengthens if management supports the FY outlook with clear deal-conversion timing and net expansion improves; upside would then come from recurring-revenue acceleration and operating leverage. Do not add if those are unsupported.
• Falsify the constructive view if guidance is cut, large bookings slip, or net expansion excluding Qubit remains near 105% without improving; that would indicate new-logo wins are not overcoming weak customer expansion. Reassess also if operating cash flow fails to turn positive in the second half as guided.
• Track quarterly gross retention, subscription revenue growth, receivables/working-capital movement, and Anglera integration costs. Until these clarify cash conversion and durable demand, no options trade or peer pair is warranted.